AP331A - Immunoassay for detecting group B streptococcus. - Google Patents

Immunoassay for detecting group B streptococcus. Download PDF

Info

Publication number
AP331A
AP331A APAP/P/1992/000377A AP9200377A AP331A AP 331 A AP331 A AP 331A AP 9200377 A AP9200377 A AP 9200377A AP 331 A AP331 A AP 331A
Authority
AP
ARIPO
Prior art keywords
antigen
agent
antibody
rhap
group
Prior art date
Application number
APAP/P/1992/000377A
Other languages
English (en)
Other versions
AP9200377A0 (en
Inventor
Harold J Jennings
Francis Michon
Robert J Chalifour
Martial Lacroix
Robert Feldman
Denis L Kasper
Vince Pozsgay
Original Assignee
Nat Res Council Canada
Brigham & Womens Hospital Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Council Canada, Brigham & Womens Hospital Inc, Harvard College filed Critical Nat Res Council Canada
Publication of AP9200377A0 publication Critical patent/AP9200377A0/xx
Application granted granted Critical
Publication of AP331A publication Critical patent/AP331A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
APAP/P/1992/000377A 1991-04-25 1992-04-24 Immunoassay for detecting group B streptococcus. AP331A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/691,310 US5225331A (en) 1991-04-25 1991-04-25 Immunoassay for detecting group b streptococcus

Publications (2)

Publication Number Publication Date
AP9200377A0 AP9200377A0 (en) 1992-04-30
AP331A true AP331A (en) 1994-04-14

Family

ID=24776026

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000377A AP331A (en) 1991-04-25 1992-04-24 Immunoassay for detecting group B streptococcus.

Country Status (15)

Country Link
US (1) US5225331A (fr)
EP (1) EP0510902B1 (fr)
JP (1) JP3270043B2 (fr)
AP (1) AP331A (fr)
AT (1) ATE139846T1 (fr)
AU (1) AU664366B2 (fr)
CA (1) CA2109090A1 (fr)
DE (1) DE69211762D1 (fr)
DK (1) DK0510902T3 (fr)
ES (1) ES2093194T3 (fr)
IE (2) IE921232A1 (fr)
IL (1) IL101656A (fr)
NZ (1) NZ242433A (fr)
WO (1) WO1992019969A1 (fr)
ZA (1) ZA922975B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044777A1 (en) * 1993-10-28 2003-03-06 Kenneth L. Beattie Flowthrough devices for multiple discrete binding reactions
EP0699906B1 (fr) 1994-07-25 2002-04-24 Roche Diagnostics GmbH Méthode de détecter la contamination d'une surface avec une analyte
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5858991A (en) 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US6004754A (en) * 1998-01-21 1999-12-21 Becton Dickinson And Company DNA sequence, related probes and primers for the detection of Streptococcus agalactiae
WO1999042588A2 (fr) * 1998-02-20 1999-08-26 Biochem Pharma Inc. Antigenes du streptocoque du groupe b
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
CA2364983A1 (fr) * 2000-12-13 2002-06-13 John R. Coleman Molecules d'acide nucleique et polypeptides pour le catabolisme de l'acide abscisique
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US6720160B2 (en) * 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
ES2381967T3 (es) * 2002-02-11 2012-06-04 Id Biomedical Corporation Antígeno de streptococcus del grupo B
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业(如皋)有限公司 含生物活性物质的兔皮和其用途
EP1845944A4 (fr) * 2005-02-08 2011-07-27 Id Biomedical Corp Of Quebec C O B As Glaxosmithkline Biolog North America Compositions pharmaceutiques
CA2766272C (fr) 2009-06-26 2021-02-09 Soricimed Biopharma Inc. Peptides derives de la soricidine, procedes de detection de cancers exprimant trpv-6 et administration de medicament
CN111690711A (zh) * 2020-07-13 2020-09-22 北京海关技术中心 棉签中铜绿假单胞菌定性检测能力验证样品及其制备方法
CN115856319B (zh) * 2022-11-30 2023-07-28 中拓生物有限公司 一种可溶性生长刺激表达基因2蛋白测定试剂盒及其制备方法和应用
CN116804674A (zh) * 2023-08-03 2023-09-26 郑州安图生物工程股份有限公司 一种肺炎链球菌尿抗原elisa试剂盒及其制备方法
CN118707093A (zh) * 2024-06-03 2024-09-27 广州华澳生物科技有限公司 一种b族链球菌的时间分辨荧光层析检测方法和检测试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003987A1 (fr) * 1985-12-17 1987-07-02 Southwest Research Institute Procede et appareil de detection et de localisation de fuites dans des garnitures de geomembrane

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF CLINICAL MICROBIOLOGY vol. 19, no. 4, 1 April 1984, WASHINGTON D.C. U.S.A PAGES 457 - 459 *

Also Published As

Publication number Publication date
EP0510902B1 (fr) 1996-06-26
IE921232A1 (en) 1992-11-04
IL101656A0 (en) 1992-12-30
WO1992019969A1 (fr) 1992-11-12
IE921344A1 (en) 1992-11-04
IL101656A (en) 1997-01-10
DE69211762D1 (de) 1996-08-01
ATE139846T1 (de) 1996-07-15
ZA922975B (en) 1993-06-18
JPH06507014A (ja) 1994-08-04
JP3270043B2 (ja) 2002-04-02
CA2109090A1 (fr) 1992-10-26
DK0510902T3 (da) 1996-11-04
EP0510902A1 (fr) 1992-10-28
NZ242433A (en) 1993-05-26
AU664366B2 (en) 1995-11-16
ES2093194T3 (es) 1996-12-16
US5225331A (en) 1993-07-06
AP9200377A0 (en) 1992-04-30
AU1567592A (en) 1992-12-21

Similar Documents

Publication Publication Date Title
AP331A (en) Immunoassay for detecting group B streptococcus.
US9989529B2 (en) Method for detection of Legionella bacteria employing purified antigen-specific antibodies
US4831126A (en) Antigenic polysaccharide specific to Brucella abortus and Yersinia enterocolitica serotype 0:9
Tikkanen et al. The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies
EP2261666B1 (fr) Procédé de détection de pneumocoque
US8420607B2 (en) Anthrax carbohydrates, synthesis and uses thereof
Anthony et al. Human antibody to the group-specific polysaccharide of group B Streptococcus
US9310366B2 (en) Anthrax carbohydrates, synthesis and uses thereof
Bossé et al. Capsular polysaccharide antigens for detection of serotype-specific antibodies to Actinobacillus pleuropneumoniae
EP1112495B1 (fr) Derives de disaccharides
Linzer et al. Serological purification of polysaccharide antigens from Streptococcus mutans serotypes a and d: characterization of multiple antigenic determinants
US20080096236A1 (en) Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof
Mårtensson et al. A monoclonal antibody specific for non-reducing terminal Galα1-4Gal residues
AU2001241867B2 (en) Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
EP0193431A1 (fr) Anticorps monoclonaux contre un lypopolysaccharide spécifique de chlamydia
Chalifour et al. Use of defined oligosaccharide epitopes in an ELISA for group B streptococcus